Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

SakuraBead - pain agnostic treatment for everyone

Objetivo

At CrannMed we are developing resorbable embolic microspheres to unlock the growing potential of vascular embolization. We call this technology SakuraBead.

Our new approach to the treatment of chronic MSK pain is based on a recent unifying understanding of the mechanism of the disease.
Previously chronic MSK pain was considered to be a wear and tear disease, but recent research suggests that the underlying root cause is a self-propagating chronic inflammatory process. This inflammatory process is characterized by the presence of neo-vessels in the tissue surrounding the site of pain. Deactivation of these neo-vessels via embolization treats the mechanism of action of the disease and disrupts the pain pathway promising years of pain free living. Effectively, our technology can turn off the mechanism of pain by interrupting the inflammatory process that sustains it. The technology has been validated in a human clinical studies focused on knee osteoarthritis which resulted in significant and long term pain relief.

SakuraBead will be the world’s first embolic that can be delivered by direct injection in an outpatient setting. Should the technology achieve its full potential it can replace upwards of 50 million steroid injections per year.
Clinical validation of the technology in expanded anatomical locations is a large part of the project.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2025-ACCELERATOR-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

CRANNMED LTD
Aportación neta de la UEn
€ 2 366 802,08
Dirección
TRUSKEY BARNA
H91XW6Y Galway
Irlanda
Pyme
Sí
Región
Ireland Northern and Western West
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos